InvestorsChronicle of the WeekTime to shut the door on this FTSE 100 ReitThere are plenty of execution risks in its grand transformation planSave4 December 2025
InvestorsChronicle of the WeekCount on quality with this pharma stockA couple of pivotal years should see the Swiss giant through its patent erosionSave27 November 2025
InvestorsChronicle of the WeekA wealth preservation trust for bearish investorsThis trust is built to hold up well in a crisisSave27 November 2025
InvestorsChronicle of the WeekA transformation is under way at this IPO disappointmentPoor sentiment and an unusual structure mean this rejuvenated media stock trades at an exceptionally low discountSave20 November 2025
InvestorsChronicle of the WeekBanks are on a bull run – but this one remains a bargainShares are already up 150 per cent, but there’s more to come once legacy issues are resolvedSave20 November 2025
InvestorsChronicle of the WeekMistaken AI woes are making this British champion a bargainThe group’s data and analytics business provides a deep moat to fend off potential disrupters Save13 November 2025
InvestorsChronicle of the WeekThis trust is a smart play on Japanese market reforms Opportunities abound in the Japanese small-cap space, and this fund will help you find them Save13 November 2025
InvestorsChronicle of the WeekA nuts and bolts manufacturer that’s fixing its weak spotsHaving lost its focus, this bargain-priced fastener firm is recuperating and broadening its scopeSave6 November 2025
InvestorsChronicle of the WeekThis nicotine giant is shedding its ‘sin stock’ discountShares are rallying as it increasingly becomes a ‘smoke-free’ business and a ‘best-in-class compounder’Save6 November 2025
InvestorsChronicle of the WeekThis stock has a clean balance sheet and a bargain share priceDespite record profitability, this cleaning products manufacturer’s valuation is yet to catch upSave30 October 2025